Cav3.1 overexpression is associated with negative characteristics and prognosis in non-small cell lung cancer

Abstract

Cav3.1 overexpression is a potential biomarker for poorer patient outcomes. These results bring supportive evidence for calcium channels inducing an aggressive phenotype in NSCLC and potentially may serve as a therapeutic target in overexpressing tumors.